Kidney cancer: Interferon-alpha (INF): An addition of 13-cis-retinoic acid to interferon-alpha (INF) in treatment of progressive metastatic renal cancer provides significantly better results on disease-free and median overall survival than interferon-alpha (INF) said large phase II / III study. See under Interferon-alpha (INF) in alphabetical list

  • Interferon-alpha (INF): An addition of 13-cis-retinoic acid to interferon-alpha (INF) in treatment of progressive metastatic renal cancer provides significantly better results on disease-free and median overall survival than interferon-alpha (INF), said large phase II / III study. See under Interferon-alpha (INF) in alphabetical list